fbpx
Skip to main content

Lunula Laser®

The Lunula is the First and ONLY NON-Thermal FDA Cleared Laser for patients with Onychomycosis. The state-of-the-Art procedure is Completely self-operating and clinically proven to produce the most effective results on the market.

Product Description

Erchonia’s forward-thinking products are designed with the patient’s experience in mind, and the best way to ensure an effective, pleasant user experience is through rigorous clinical trials. The Lunula laser was cleared by the FDA to promote clear nail growth based on real results found in three Erchonia Corporation clinical tests.

Based on these six-month trials, 67 percent of evaluated toenails reached a clear growth of 3mm or more. The average increase in growth was over 5mm.

Today, Lunula’s innovative low-level laser technology has helped many sufferers of onychomycosis reduce symptoms and enjoy the lasting confidence of clear, healthy nails. If you’re interested in seeing what Lunula foot fungus laser treatments can do for you or your patients, contact us today to purchase, or search for a provider to find Lunula treatments near you.

How it Works

The Erchonia Lunula Laser uses low-level laser light to target onychomycosis and requires very little time or set-up for physicians or their staff. This cutting-edge foot fungus laser treatment is the only system you can turn on and walk away – the device already has a pre-set protocol. In fact, as little as (4) 12-minute sessions are needed to treat the affected area.

Specifications

  • Configuration: 2 class 2 Line Generated Laser Diode Modules
  • Wavelength: 635nm & 405nm
  • Modulation: Constant Wave (CW)
  • Display: Full Color TFT Touch Screen Control Center
  • Power Source: 100-240VAC 50-60Hz
  • Chassis: Powder Coated Aircraft Aluminum
  • Treatment Area: 304 Stainless Steel for Anti-Microbial Properties
  • Housing: Injection Molded Process with Non-Allergen Material/Plastic
  • Weight: 23Ibs. (10.43 kg)
  • Accessories: 2-Keys, Power Cord & Laser Safety Glasses
  • Compliant to: ISO 13485 Medical Device Quality, IEC 60825-1 Laser Safety, IEC 60601-1 MEE Safety, IEC 60601-1-2 EMC, CB Mark, CE Mark, CMDCAS

*Individual results may vary.

Treatment

  • Unlimited Usage
  • Only 12-minute treatments
  • Treats all 5 toes at once
  • Non-invasive
  • No Heat, No Pain
  • Unattended Treatment

For Medical Professionals

More patients and medical professionals are trusting Lunula laser therapy to effectively target the symptoms of onychomycosis. Using cold lasers specifically designed to target toenail fungus.

Best of all, Lunula is both easy and safe to use. As with each of Erchonia’s low-level lasers, Lunula is held to the highest safety standards and has been tested in the strictest trial conditions for effectiveness and safety. Because the Lunula laser uses extremely low wavelengths and frequencies, most patients experience no discomfort, burning, searing or pain of any kind. Each onychomycosis laser treatment is performed while the patient is awake, reducing downtime and allowing users to go about the rest of their day effortlessly.

Experience the Erchonia advantage when you use innovative Lunula laser treatments to target toenail fungus, with benefits such as:

  • No pain, risks or downtime
  • No dangerous lasers or smoke fumes
  • Unattended procedure while the patient is awake
  • 89 percent patient response to treatments
  • Made in the U.S.

Rental Program

The subscription business model allows doctors to simply run unlimited uses without having to pay-per-use or pay the full purchase price of the device.

Set-up Fee: $3,000
Start-up Fee: $750 per month

Includes:

  • Lunula Laser device
  • Unlimited Warranty
  • Counter card
  • 100 pack patient brochures
  • Window Poster
  • Unlimited access to online marketing portal
  • Certified provider listing on Lunula website
  • Access to our marketing specialist and dedicated clinical educator

Treatment Cost (ROI)

National Average treatment charge is $600 for one foot, $900 for two feet (Most Patients will opt for both feet). Added cost for severe cases that require additional treatments. ​On average, providers in the United States treat four patients per month. In the United States, providers are currently making $3,600 per month

How It Works

#